Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × First-line Treatment × Gastrointestinal × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1148 Pancreatic Neoplasms 733 Carcinoma, Hepatocellular 691 Stomach Neoplasms 678 Rectal Neoplasms 501 Esophageal Neoplasms 402 Colonic Neoplasms 366 Esophageal Squamous Cell Carcinoma 249 Neoplasm Metastasis 240 Cholangiocarcinoma 217 Liver Neoplasms 192 Neoplasms 180 Biliary Tract Neoplasms 153 Adenocarcinoma Of Esophagus 125 Gastrointestinal Stromal Tumors 100 Gallbladder Neoplasms 85 Adenocarcinoma 85 Gastrointestinal Neoplasms 82 Breast Neoplasms 78 Carcinoma, Non-Small-Cell Lung 77 Bile Duct Neoplasms 62 Sarcoma 59 Lung Neoplasms 56 Ovarian Neoplasms 52 Anus Neoplasms 50 Melanoma 48 Carcinoma 47 Digestive System Neoplasms 42 Uterine Cervical Neoplasms 36 Prostatic Neoplasms 35

Interventions

trifluridine tipiracil drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05077839 2021-10-25

TOBACO

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Gastrointestinal

First-line Treatment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡